Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2007-03-13
2007-03-13
Webman, Edward J. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C514S772700, C514S786000, C514S787000
Reexamination Certificate
active
10075184
ABSTRACT:
Degradable blend of polycaprolactone and crystallization modifier especially suitable for use in the controlled release of biologically active proteins
REFERENCES:
patent: 2576576 (1951-11-01), Cresswell et al.
patent: 3896814 (1975-07-01), Vivien et al.
patent: 4137279 (1979-01-01), Smith et al.
patent: 4201216 (1980-05-01), Mattei
patent: 4624256 (1986-11-01), Messier et al.
patent: 4649920 (1987-03-01), Rhum
patent: 4786501 (1988-11-01), Janski et al.
patent: 5084267 (1992-01-01), Damani
patent: 5278201 (1994-01-01), Dunn et al.
patent: 5378540 (1995-01-01), Olson
patent: 5380780 (1995-01-01), Olson
patent: 5610214 (1997-03-01), Olson
patent: 5641502 (1997-06-01), Skalla et al.
patent: 5741600 (1998-04-01), Olson
A.M. Klibanov et al., “A New Approach to Preparative Enzymatic Synthesis”; Biotechnology & Bioengineering, vol. XIX, pp. 1351-1361 (1977) by John Wiley & Sons, Inc.
“Final Report on the Safety Assessment of Blyceryl Sterate and Glyceryl Stearate/SE”: J. Am. College Toxicology, vol. 1, No. 4, 12982, pp. 169-192 (1982).
Rong-Kun Chang, James C. Price and Clyde W. Whitworth, “Control of Drug Release Rates Through the Use of Mixtures of Polycaprolactone and Cellulose Propionate Polymers”;Pharm Technol., pp. 24-33, Oct. 1986.
Chang et al., “Control of Drug Release Rate by Use of Mixtures of Polycaprolactone and Cellulose Acetate Butyrate Polymers”; Drug Dev. & Indus. Pharmacy, 13(6), 1119-1135 (1987).
J. Heller, “Synthesis and Use of Poly (Ortho Esters) for the Controlled Delivery of Therapeutic Agents”; Technomic Pub. Co. Inc. 1988, J. Bioactive and Compatible Polymers, vol. 3, Apr. 1988, pp. 97-105.
C.G. Pitt et al., “Aliphatic Polyesters. 1. The Degradation of Poly(E-Caprolactone) In vivo”; Journal of Applied Polymer Science, vol. 26, 3779-3787 (1981).
Calias Pericles
Miller Robert J.
Olson James R.
Cohen & Pontani, Lieberman & Pavane
Genzyme Corporation
Webman Edward J.
LandOfFree
Drug delivery of proteins from polymeric blends does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug delivery of proteins from polymeric blends, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug delivery of proteins from polymeric blends will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3799163